BIOMAT Database Logo BIOMAT Database Logo

Hydroxocobalamin uptake into the cerebrospinal fluid after nasal and intravenous delivery in rats and humans. 2003

Mascha P Van den Berg, and Paul Merkus, and Stefan G Romeijn, and J Coos Verhoef, and Frans W H M Merkus
Division of Pharmaceutical Technology and Biopharmaceutics, Leiden/Amsterdam Center for Drug Research, Leiden University, P.O. Box 9502 2300 RA Leiden, The Netherlands.

The possibility of direct transport of hydroxocobalamin from the nasal cavity into the cerebrospinal fluid (CSF) after nasal administration in rats was investigated and the results were compared with a human study. Hydroxocobalamin was given to rats (n=8) both intranasally (214 microg/rat) and intravenously (49.5 microg/rat) into the jugular vein using a Vascular Access Port (VAP). Prior to and after drug administration, blood and CSF samples were taken and analysed by radioimmunoassay. The AUCCSF/AUCplasma ratio after nasal delivery does not differ from the ratio after intravenous infusion, indicating that hydroxocobalamin enters the CSF via the blood circulation across the blood-brain barrier (BBB). This same transport route is confirmed by the cumulative AUC-time profiles in CSF and plasma, demonstrating a 30 min delay between plasma absorption and CSF uptake of hydroxocobalamin in rats and in a comparative human study. The present results in rats show that there is no additional uptake of hydroxocobalamin in the CSF after nasal delivery compared to intravenous administration, which is in accordance with the results found in humans. This indicates a predictive value of the used rat model for the human situation when studying the nose to CSF transport of drugs.

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D008297 Male Males
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D002408 Catheters, Indwelling Catheters designed to be left within an organ or passage for an extended period of time. Implantable Catheters,In-Dwelling Catheters,Catheter, In-Dwelling,Catheter, Indwelling,Catheters, In-Dwelling,In Dwelling Catheters,In-Dwelling Catheter,Indwelling Catheter,Indwelling Catheters
D002626 Chemistry, Pharmaceutical Chemistry dealing with the composition and preparation of agents having PHARMACOLOGIC ACTIONS or diagnostic use. Medicinal Chemistry,Chemistry, Pharmaceutic,Pharmaceutic Chemistry,Pharmaceutical Chemistry,Chemistry, Medicinal
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006879 Hydroxocobalamin Injectable form of VITAMIN B 12 that has been used therapeutically to treat VITAMIN B 12 DEFICIENCY. Hydroxycobalamin,Hydroxo-Cobalamin
D000281 Administration, Intranasal Delivery of medications through the nasal mucosa. Drug Administration, Intranasal,Administration, Intranasal Drug,Administration, Nasal,Intranasal Administration,Intranasal Drug Administration,Administrations, Intranasal,Administrations, Intranasal Drug,Administrations, Nasal,Drug Administrations, Intranasal,Intranasal Administrations,Intranasal Drug Administrations,Nasal Administration,Nasal Administrations
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D017208 Rats, Wistar A strain of albino rat developed at the Wistar Institute that has spread widely at other institutions. This has markedly diluted the original strain. Wistar Rat,Rat, Wistar,Wistar Rats

Related Publications

Mascha P Van den Berg, and Paul Merkus, and Stefan G Romeijn, and J Coos Verhoef, and Frans W H M Merkus
Brain and cerebrospinal fluid uptake of zidovudine (AZT) in rats after intravenous injection.
January 1990, Life sciences,
Mascha P Van den Berg, and Paul Merkus, and Stefan G Romeijn, and J Coos Verhoef, and Frans W H M Merkus
Uptake kinetics of 2',3'-dideoxyinosine into brain and cerebrospinal fluid of rats: intravenous infusion studies.
April 1990, The Journal of pharmacology and experimental therapeutics,
Mascha P Van den Berg, and Paul Merkus, and Stefan G Romeijn, and J Coos Verhoef, and Frans W H M Merkus
Penetration of trovafloxacin into cerebrospinal fluid in humans following intravenous infusion of alatrofloxacin.
June 1997, Antimicrobial agents and chemotherapy,
Mascha P Van den Berg, and Paul Merkus, and Stefan G Romeijn, and J Coos Verhoef, and Frans W H M Merkus
Fluconazole penetration into cerebrospinal fluid in humans.
April 1988, Journal of clinical pharmacology,
Mascha P Van den Berg, and Paul Merkus, and Stefan G Romeijn, and J Coos Verhoef, and Frans W H M Merkus
Thyrotropin releasing hormone uptake into serum and cerebrospinal fluid following intravenous or subcutaneous administration.
December 1988, Neurological research,
Mascha P Van den Berg, and Paul Merkus, and Stefan G Romeijn, and J Coos Verhoef, and Frans W H M Merkus
Ketorolac penetration into the cerebrospinal fluid of humans.
January 1993, Journal of clinical anesthesia,
Mascha P Van den Berg, and Paul Merkus, and Stefan G Romeijn, and J Coos Verhoef, and Frans W H M Merkus
Cerebrospinal fluid binding capacity for cyano- and hydroxocobalamin.
January 1966, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
Mascha P Van den Berg, and Paul Merkus, and Stefan G Romeijn, and J Coos Verhoef, and Frans W H M Merkus
Entry of tromethamine into the cerebrospinal fluid of humans after cerebrovascular events.
July 1999, Clinical pharmacology and therapeutics,
Mascha P Van den Berg, and Paul Merkus, and Stefan G Romeijn, and J Coos Verhoef, and Frans W H M Merkus
Nasal absorption of (S)-UH-301 and its transport into the cerebrospinal fluid of rats.
February 2000, International journal of pharmaceutics,
Mascha P Van den Berg, and Paul Merkus, and Stefan G Romeijn, and J Coos Verhoef, and Frans W H M Merkus
Paracetamol (acetaminophen) penetrates readily into the cerebrospinal fluid of children after intravenous administration.
April 2007, Pediatrics,
Copied contents to your clipboard!